Eric Schadt's guest appearances

Eric Schadt

Medscape Infectious Disease Podcast

Medscape Critical Care Podcast

Medscape Emergency Medicine Podcast

Medscape Pharmacists Podcast

Medscape Allergy & Immunology Podcast

Medscape Pulmonary Medicine Podcast

Mendelspod Podcast

Medscape Gastroenterology Podcast

Medscape Ophthalmology Podcast

Medscape Plastic Surgery and Aesthetic Podcast

Hidden Forces

CSHL Keynote Series

Annie Duke

Mike Maloney

Jim Rickards

Nathaniel Whittemore

David Epstein

Chris Burniske

Eve Ensler

Cal Newport

Rick Rule

Chris Mason

Ben Hunt

Andrew Yang

Jerry Colonna

Noam Chomsky

Rob Knight

OwlTail

"We like to refer to it as consumer initiated, but physician supervised,” says Eric Schadt today when asked if his new test is direct-to-consumer.Eric is the Dean for Precision Medicine at the Icahn School of Medicine at Mount Sinai in New York and since 2016 has served as CEO of Sema4, a spinoff that he founded out of the Mount Sinai Health System.  Sema4 launched a newborn screening panel, Sema4 Natalis, in February of this year covering over 190 disorders.

"We like to refer to it as consumer initiated, but physician supervised,” says Eric Schadt today when asked if his new test is direct-to-consumer. Eric is the Dean for Precision Medicine at the Icahn School of Medicine at Mount Sinai in New York and since 2016 has served as CEO of Sema4, a spinoff that he founded out of the Mount Sinai Health System. Sema4 launched a newborn screening panel, Sema4 Natalis, in February of this year covering over 190 disorders.

Eric Schadt and Sema4 Try the Consumer Model with Newborn Screening Panel

In Episode 15 of Hidden Forces, host Demetri Kofinas speaks with Dr. Eric Schadt. Eric Schadt is founder and CEO of Sema4, as well as Dean of Precision Medicine at the Icahn School of Medicine at Mount Sinai. During the course of his 20-year career, Dr. Eric Schadt has built genetics and systems biology groups at Merck. He built the computational biology group at Rosetta. He has served as co-founder of Sage Bionetworks and as Chief Science Officer of Pacific Biosciences. He now serves as the founder and CEO of Sema4. He has published more than 300 peer-reviewed papers in leading scientific journals, and he has contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity and Alzheimer’s. In today’s conversation, we explore the information technology of biology – DNA – the world of genomics, where big data looms large. We begin by mapping the territory of the human genome and exploring the pathways of disease. We look to understand the ways in which complex genetic combinations express themselves as phenotypes such as height, bone structure, intelligence, and personality. How are these traits coded for? What are the instructions our body uses to repair a damaged cell? What blueprint does it consult before trying to grow new arteries? How does it know to regulate our appetite or when start us down the path of puberty? What happens when these instructions are damaged? How can the smallest difference in the order of life’s code make all the difference for our success, our happiness, and even our survival? 50 years have passed, between the discovery of the double-helix and the mapping of the first human genome. What progress have we made in the 15 years since? How has our ability to sequence new genomes created a paradigm shift in medicine? What is the role of big data and artificial intelligence in finding the correlations needed in order to treat malignancies and prevent diseases? What is the promise of genomics? What are the perils of big data in medicine? What stands between us and some superhuman future? Producer &amp; Host: Demetri Kofinas Editor &amp; Engineer: Stylianos Nicolaou Join the conversation on Facebook, Instagram, and Twitter at @hiddenforcespod

In Episode 15 of <a href="https://www.hiddenforces.io" rel="nofollow" target="_blank">Hidden Forces</a>, host Demetri Kofinas speaks with Dr. Eric Schadt. Eric Schadt is founder and CEO of Sema4, as well as Dean of Precision Medicine at the Icahn School of Medicine at Mount Sinai. During the course of his 20-year career, Dr. Eric Schadt has built genetics and systems biology groups at Merck. He built the computational biology group at Rosetta. He has served as co-founder of Sage Bionetworks and as Chief Science Officer of Pacific Biosciences. He now serves as the founder and CEO of Sema4. He has published more than 300 peer-reviewed papers in leading scientific journals, and he has contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity and Alzheimer’s. In today’s conversation, we explore the information technology of biology – DNA – the world of genomics, where big data looms large. We begin by mapping the territory of the human genome and exploring the pathways of disease. We look to understand the ways in which complex genetic combinations express themselves as phenotypes such as height, bone structure, intelligence, and personality. How are these traits coded for? What are the instructions our body uses to repair a damaged cell? What blueprint does it consult before trying to grow new arteries? How does it know to regulate our appetite or when start us down the path of puberty? What happens when these instructions are damaged? How can the smallest difference in the order of life’s code make all the difference for our success, our happiness, and even our survival? 50 years have passed, between the discovery of the double-helix and the mapping of the first human genome. What progress have we made in the 15 years since? How has our ability to sequence new genomes created a paradigm shift in medicine? What is the role of big data and artificial intelligence in finding the correlations needed in order to treat malignancies and prevent diseases? What is the promise of genomics? What are the perils of big data in medicine? What stands between us and some superhuman future? Producer &amp; Host: <a href="http://www.demetrikofinas.com/" rel="nofollow" target="_blank">Demetri Kofinas</a> Editor &amp; Engineer: Stylianos Nicolaou Join the conversation on <a href="https://www.facebook.com/hiddenforcespod/" rel="nofollow" target="_blank">Facebook</a>, <a href="https://www.instagram.com/hiddenforcespod/" rel="nofollow" target="_blank">Instagram</a>, and <a href="https://twitter.com/hiddenforcespod" rel="nofollow" target="_blank">Twitter</a> at @hiddenforcespod

Genomics, Machine Learning, and the Future of Big Data in Medicine | Eric Schadt

Guest:Eric Schadt, Professor &amp; Chair Genetics and Genomic Sciences, Director Icahn Institute for Genomics and Multiscale Biology   Bio and Contact Info  Listen (5:01) Getting buy-in from a few lead doctors

Guest: Eric Schadt, Professor &amp; Chair Genetics and Genomic Sciences, Director Icahn Institute for Genomics and Multiscale Biology <a href="http://mendelspod.com/guests/eric-schadt" rel="nofollow" target="_blank">Bio and Contact Info</a> <a href="http://mendelspod.com/podcast/getting-buy-few-lead-doctors" rel="nofollow" target="_blank"> Listen (5:01)</a> Getting buy-in from a few lead doctors

 Eric Schadt on Long Read Sequencing and Clinical Genomics